Why Collegium Pharmaceutical (COLL) Could Beat Earnings Estimates Again

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Collegium Pharmaceutical (COLL) , which belongs to the Zacks Medical - Drugs industry.This specialty pharmaceutical company has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of 5.67%.For the last reported quarter, Collegium Pharmaceutic ...